loadpatents
name:-0.035514116287231
name:-0.026123046875
name:-0.020350933074951
Dahl; Russell Patent Filings

Dahl; Russell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dahl; Russell.The latest application filed is for "quinolines that modulate serca and their use for treating disease".

Company Profile
35.33.46
  • Dahl; Russell - Saint John IN
  • Dahl; Russell - Carlsbad CA
  • Dahl; Russell - La Jolla CA
  • Dahl; Russell - North Chicago IL
  • Dahl; Russell - US
  • Dahl; Russell - Newbury Park CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinolines That Modulate Serca And Their Use For Treating Disease
App 20220048898 - Dahl; Russell
2022-02-17
Quinolines That Modulate Serca And Their Use For Treating Disease
App 20220016108 - Dahl; Russell
2022-01-20
Neuroprotective aminothiazoles
Grant 11,220,498 - Dahl January 11, 2
2022-01-11
Neuroprotective quinoline sulfonamides
Grant 11,213,701 - Dahl January 4, 2
2022-01-04
Quinoline Sulfonamides Useful To Treat Disease
App 20210323924 - Dahl; Russell
2021-10-21
Quinoline Amines Useful As Cytoprotective Agents
App 20210269404 - Dahl; Russell
2021-09-02
Quinolines That Modulate Serca And Their Use For Treating Disease
App 20200347038 - Dahl; Russell
2020-11-05
Quinoline alkenes as cytoprotective agents
Grant 10,800,766 - Dahl October 13, 2
2020-10-13
Quinoline oxadiazoles as cytoprotective agents
Grant 10,793,558 - Dahl October 6, 2
2020-10-06
Quinolines that modulate SERCA and their use for treating disease
Grant 10,772,881 - Dahl Sept
2020-09-15
Quinolines as cytoprotective agents
Grant 10,730,839 - Dahl
2020-08-04
Quinoxalines useful as cytoprotective agents
Grant 10,730,843 - Dahl
2020-08-04
Neuroprotective Quinoline Sulfonamides
App 20200188706 - Dahl; Russell
2020-06-18
Neuroprotective Aminothiazoles
App 20200190078 - Dahl; Russell
2020-06-18
Neuroprotective Hydrazides
App 20200190077 - Dahl; Russell
2020-06-18
Quinoline Amines Useful As Cytoprotective Agents
App 20200039939 - Dahl; Russell
2020-02-06
Quinoline Oxadiazoles As Cytoprotective Agents
App 20190375741 - Dahl; Russell
2019-12-12
Quinoline Alkenes As Cytoprotective Agents
App 20190375737 - Dahl; Russell
2019-12-12
Benzothiazole or benzoxazole compounds as SUMO activators
Grant 10,501,453 - Dahl , et al. Dec
2019-12-10
Quinoline Sulfonamides Useful To Treat Disease
App 20190337899 - Dahl; Russell
2019-11-07
Quinolines As Cytoprotective Agents
App 20190330156 - Dahl; Russell
2019-10-31
Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases
Grant 10,383,868 - Dahl A
2019-08-20
Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders
Grant 10,383,867 - Dahl A
2019-08-20
Sulfonamide compounds and uses as TNAP inhibitors
Grant 10,370,333 - Pinkerton , et al.
2019-08-06
Sulfonamide Compounds And Uses As Tnap Inhibitors
App 20190010126 - PINKERTON; Anthony B. ;   et al.
2019-01-10
Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
Grant 10,099,993 - Dhanya , et al. October 16, 2
2018-10-16
Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
Grant 10,011,578 - Stutzmann , et al. July 3, 2
2018-07-03
Benzothiazole Or Benzoxazole Compounds As Sumo Activators
App 20180127407 - Dahl; Russell ;   et al.
2018-05-10
Sulfonamide compounds and uses as TNAP inhibitors
Grant 9,884,826 - Pinkerton , et al. February 6, 2
2018-02-06
Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release
App 20180022722 - Stutzmann; Grace E. ;   et al.
2018-01-25
Benzothiazole or benzoxazole compounds as sumo activators
Grant 9,845,320 - Dahl , et al. December 19, 2
2017-12-19
Quinolines And Their Use For Treating Endoplasmic Reticulum Stress-caused Diseases
App 20170281611 - DAHL; Russell
2017-10-05
Quinoline Containing Compounds And Their Use For Treating Endoplasmic Reticulum Stress-related Diseases
App 20170231973 - Dahl; Russell
2017-08-17
Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
Grant 9,725,429 - Stutzmann , et al. August 8, 2
2017-08-08
Quinoline Derivatives And Their Use For Treating Endoplasmic Reticulum Stress-related Diseases And Disorders
App 20170151225 - Dahl; Russell
2017-06-01
Sulfonamide Compounds And Uses As Tnap Inhibitors
App 20160355479 - PINKERTON; Anthony B. ;   et al.
2016-12-08
Sulfonamide compounds and uses as TNAP inhibitors
Grant 9,458,147 - Pinkerton , et al. October 4, 2
2016-10-04
Compounds For Stabilizing Ryanodine Receptors From Aberrant Levels Of Calcium Release
App 20160024038 - Stutzmann; Grace E. ;   et al.
2016-01-28
Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
Grant 9,102,645 - Stutzmann , et al. August 11, 2
2015-08-11
Benzothiazole Or Benzoxazole Compounds As Sumo Activators
App 20150218148 - Dahl; Russell ;   et al.
2015-08-06
Sulfonamide Compounds And Uses As Tnap Inhibitors
App 20150011551 - Pinkerton; Anthony B. ;   et al.
2015-01-08
Compounds For Stabilizing Ryanodine Receptors From Aberrant Levels Of Calcium Release
App 20140275112 - Stutzmann; Grace E. ;   et al.
2014-09-18
Benzoisothiazolones As Inhibitors Of Phosphomannose Isomerase
App 20110257233 - Cosford; Nicholas D. P. ;   et al.
2011-10-20
Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma
App 20110166216 - Ronai; Ze'ev A. ;   et al.
2011-07-07
Cytokine inhibitors
Grant 7,919,617 - Boman , et al. April 5, 2
2011-04-05
Cytokine inhibitors
Grant 7,897,599 - Boman , et al. March 1, 2
2011-03-01
Compositions and methods for inhibiting growth and metastasis of melanoma
Grant 7,888,355 - Ronai , et al. February 15, 2
2011-02-15
Compositions And Methods For Inhibiting Growth And Metastasis Of Melanoma
App 20100305129 - Ronai; Zeev A. ;   et al.
2010-12-02
Alpha-ketoamides And Derivatives Thereof
App 20100273797 - Boman; Erik ;   et al.
2010-10-28
Compositions and methods for inhibiting growth and metastasis of melanoma
Grant 7,776,894 - Ronai , et al. August 17, 2
2010-08-17
Alpha-ketoamides and derivatives thereof
Grant 7,749,999 - Boman , et al. July 6, 2
2010-07-06
Cytokine Inhibitors
App 20100093734 - Boman; Erik ;   et al.
2010-04-15
Cytokine Inhibitors
App 20100093735 - Boman; Erik ;   et al.
2010-04-15
Compositions And Methods For Inhibiting Growth And Metastasis Of Melanoma
App 20090054438 - Ronai; Ze'ev A. ;   et al.
2009-02-26
Modulators Of The Glucocorticoid Receptor And Method
App 20070232648 - Dahl; Russell ;   et al.
2007-10-04
Cytokine inhibitors
App 20050107399 - Boman, Erik ;   et al.
2005-05-19
Optical tracking system
Grant 6,094,007 - Faul , et al. July 25, 2
2000-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed